查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888579

全球解剖病理学市场：市场规模、份额和趋势分析（按产品/服务、应用、最终用途和地区划分），细分市场预测（2025-2033 年）

Anatomic Pathology Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables, Services), By Application (Disease Diagnosis, Drug Discovery And Development), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

解剖病理学市场概览

2024年全球解剖病理学市场规模估计为347.2亿美元，预计2033年将达到807.8亿美元。

预计从 2025 年到 2033 年，该市场将以 9.79% 的复合年增长率成长。推动市场成长的关键因素包括全球癌症和慢性疾病负担的加重、精准医疗和个人化医疗的日益普及，以及数位病理学和人工智慧 (AI) 技术的进步。

例如，2025年7月，PathAI（美国）推出了精准病理网路（PPN），这是全球首个配备该公司AISight 1影像管理系统（IMS）的数位解剖病理实验室网路。 PPN旨在让参与实验室能够儘早使用PathAI与生物製药产业合作开发的最新人工智慧病理解决方案，从而实现真实世界病理数据的商业化，支持生物製药公司进行循证研究，并推动利用人工智慧病理学的新型临床开发策略。此外，人口老化和不断增长的医疗保健需求正在推动全球解剖病理产业的成长。根据《2024年世界人口展望》，未来50至60年世界人口预计将持续成长，从2024年的82亿增加到2080年代中期的约103亿。

分子病理学和伴随诊断（CDx）的进步使得疾病诊断和治疗更加精准、个人化和标靶治疗，显着扩大了全球市场。分子病理学透过检测与特定疾病（尤其是癌症）相关的基因、分子和细胞改变，实现更早期、更准确的诊断。伴随诊断透过识别最有可能从特定治疗方法中获益的患者，指导标靶治疗的应用。这种诊断与治疗相结合的方法正日益应用于肿瘤学和其他医学领域，推动了对先进病理服务的需求。随着製药公司持续投资于个人化医疗，监管机构也鼓励将伴随诊断整合到药物研发过程中，解剖病理学的角色正从传统的组织学扩展到分子层面，加速市场成长和创新。

除了日益加重的疾病负担和技术进步之外，还有其他几个因素推动着全球解剖病理学产业的发展。患者和医疗保健提供者对早期准确诊断重要性的认识和教育程度不断提高，导致对病理诊断服务的需求增加。常规健康检查和预防性医疗保健计划的开展，使得切片检查手术量增加，从而推动了病理分析的需求。此外，医疗服务模式从医院向门诊和专业诊断中心的转变，提高了病理诊断服务的可近性和效率。已开发国家优惠的报销政策以及新兴经济体政府为加强诊断基础设施所采取的支持措施，也进一步推动了市场成长。

此外，诊断实验室、医院和科技公司之间的策略联盟、合併和收购正在推动创新，并有助于扩大各地区的服务范围。

目录

第一章 解剖病理学市场：调查方法与范围

2. 解剖病理学市场：执行摘要

  • 市场概览
  • 产品和服务概述
  • 应用概述
  • 最终用途概述
  • 竞争格局概述

3. 解剖病理学市场：驱动因素、趋势与范围

  • 市场区隔和范围
  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 全球癌症和慢性疾病负担日益加重
    • 扩大精准医疗和个人化医疗的引入
    • 数位病理学和人工智慧（AI）的进展
    • 分子病理学和伴随诊断（CDx）的扩展
    • 老化和医疗保健的扩张
  • 市场限制因素分析
    • 先进诊断设备高成本
    • 严格的监管和合规要求
    • 资料隐私和网路安全问题
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 解剖病理学市场：按产品和服务分類的估算和趋势分析

  • 解剖病理学市场：按产品和服务分類的差异分析
  • 产品
    • 装置
    • 消耗品
    • 服务

第五章 解剖病理学市场：按应用分類的估算与趋势分析

  • 解剖病理学市场：按应用领域分類的差异分析
  • 疾病诊断
  • 药物发现与开发
  • 其他的

6. 解剖病理学市场：依最终用途分類的估算与趋势分析

  • 解剖病理学市场：按最终用途分類的差异分析
  • 医院
  • 诊断检查室
  • 研究所
  • 其他的

第七章 解剖病理学市场：按地区分類的业务分析

  • 市场概览：按地区划分
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 商业伙伴关係
    • 企业收购
    • 合资
    • 资金筹措
  • 主要企业市占率分析（2024 年）
  • 公司热力图分析
  • 公司简介
    • Danaher
    • PHC Holdings Corporation
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • F. Hoffmann-La Roche AG
    • Agilent Technologies, Inc.
    • Sakura Finetek USA, Inc.
    • NeoGenomics Laboratories, Inc.
    • BioGenex
    • Bio SB
Product Code: GVR-3-68038-318-8

Anatomic Pathology Market Summary

The global anatomic pathology market size was estimated at USD 34.72 billion in 2024 and is projected to reach USD 80.78 billion by 2033, growing at a CAGR of 9.79% from 2025 to 2033. Some of the major factors driving the market growth are rising global cancer and chronic disease burden, growing adoption of precision and personalized medicine, and digital pathology and artificial intelligence (AI) advancements.

For instance, in July 2025, PathAI (U.S.) launched the Precision Pathology Network (PPN), a first-of-its-kind network of digital anatomic pathology laboratories powered by PathAI's AISight 1 Image Management System (IMS). The PPN is intended to provide early access to the most recent AI-powered pathology solutions developed by PathAI in collaboration with the biopharma industry, to allow participating laboratories to monetize real-world pathology data, to support biopharma-sponsored evidence generation studies, and to enable novel clinical development strategies that leverage AI-pathology. Furthermore, an aging population and rising healthcare expenditure fuel the growth of the global anatomic pathology industry. As per the World Population Prospects 2024, the world's population is expected to keep growing for another 50 or 60 years, peaking at around 10.3 billion in the mid-2080s, up from 8.2 billion in 2024.

The growth of molecular pathology and companion diagnostics (CDx) is significantly increasing the global market by allowing for more precise, personalized, and targeted approaches to disease diagnosis and treatment. Molecular pathology detects genetic, molecular, and cellular changes associated with specific diseases, most notably cancer, allowing for earlier and more accurate diagnoses. Companion diagnostics help guide the use of targeted therapies by identifying patients who are most likely to benefit from specific treatments. This combination of diagnostics and therapeutics is increasingly being used in oncology and other fields of medicine, driving demand for advanced pathology services. As pharmaceutical companies continue to invest in personalized medicine and regulatory agencies encourage the incorporation of CDx into drug development pipelines, the role of anatomic pathology is expanding beyond traditional histology to include molecular insights, accelerating market growth and innovation.

In addition to rising disease burdens and technological advancements, a number of other factors are driving the global anatomic pathology industry. The growing awareness and education of patients and healthcare providers about the importance of early and accurate diagnosis is driving up demand for pathology services. The growing number of biopsy procedures, driven by routine health screenings and preventive care programs, is increasing the demand for pathology analysis. Furthermore, the transition from hospital-based care to outpatient and specialized diagnostic centers improves pathology services' accessibility and efficiency. Favorable reimbursement policies in developed countries, as well as supportive government initiatives to strengthen diagnostic infrastructure in emerging economies, are further driving market growth.

Furthermore, strategic collaborations, mergers, and acquisitions between diagnostic labs, hospitals, and technology companies are fostering innovation and expanding service offerings across regions.

Global Anatomic Pathology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the anatomic pathology market report based on product & service, application, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
    • Microtomes & Cryostat
    • Tissue Processors
    • Automatic Stainers
    • Whole Slide Imaging (WSI) Scanners
    • Other Products
  • Consumables
    • Reagents & Antibodies
    • Probes & Kits
    • Others
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Diagnosis
  • Drug Discovery and Development
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Anatomic Pathology Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Method
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Anatomic Pathology Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product & Service Snapshot
  • 2.3. Application Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Anatomic Pathology Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising Global Cancer and Chronic Disease Burden
    • 3.4.2. Growing Adoption of Precision and Personalized Medicine
    • 3.4.3. Advancements in Digital Pathology and Artificial Intelligence (AI)
    • 3.4.4. Expansion of Molecular Pathology and Companion Diagnostics (CDx)
    • 3.4.5. Aging Population and Rising Healthcare Expenditure
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Advanced Diagnostic Equipment
    • 3.5.2. Stringent Regulatory and Compliance Requirements
    • 3.5.3. Data Privacy and Cybersecurity Issues
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Anatomic Pathology Market: Product & Service Estimates & Trend Analysis

  • 4.1. Anatomic Pathology Market: Test Method Movement Analysis
  • 4.2. Products
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.2. Microtomes & Cryostat
        • 4.2.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.3. Tissue Processors
        • 4.2.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.4. Automatic Stainers
        • 4.2.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.5. Whole Slide Imaging (WSI) Scanners
        • 4.2.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.6. Other Products
        • 4.2.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.3.2. Reagents & Antibodies
        • 4.2.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.3.3. Probes & Kits
        • 4.2.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.3.4. Others
        • 4.2.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Services

Chapter 5. Anatomic Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Anatomic Pathology Market: Mode Movement Analysis
  • 5.2. Disease Diagnosis
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Drug Discovery and Development
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Anatomic Pathology Market: End Use Estimates & Trend Analysis

  • 6.1. Anatomic Pathology Market: Product & Service Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Diagnostic Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Research Laboratories
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Anatomic Pathology Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. Danaher
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. PHC Holdings Corporation
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Quest Diagnostics Incorporated
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Laboratory Corporation of America Holdings
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. F. Hoffmann-La Roche AG
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Agilent Technologies, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Sakura Finetek USA, Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. NeoGenomics Laboratories, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. BioGenex
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Bio SB
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Anatomic Pathology Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 5 Global Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 9 North America Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 North America Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 12 U.S. Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 15 Canada Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Europe Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 18 Europe Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 19 Europe Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Europe Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 UK Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 22 UK Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 UK Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 Germany Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 25 Germany Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 Germany Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 France Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 28 France Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 France Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 Italy Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 31 Italy Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 Italy Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Spain Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 34 Spain Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Spain Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Denmark Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 37 Denmark Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 38 Denmark Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Sweden Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 40 Sweden Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Sweden Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Norway Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 43 Norway Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Norway Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 Japan Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 50 Japan Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Japan Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 China Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 53 China Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 China Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 India Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 56 India Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 India Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Australia Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 59 Australia Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 Australia Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 South Korea Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 62 South Korea Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 South Korea Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Thailand Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 65 Thailand Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Latin America Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 68 Latin America Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 69 Latin America Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Latin America Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 Brazil Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 72 Brazil Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 Brazil Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Mexico Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 75 Mexico Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Mexico Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 78 Argentina Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 81 MEA Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 MEA Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 84 South Africa Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 85 South Africa Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 90 UAE Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 91 UAE Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Anatomic Pathology Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Anatomic Pathology Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Anatomic Pathology Market driver impact
  • Fig. 14 Anatomic Pathology Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Anatomic Pathology Market: Product & Service outlook and key takeaways
  • Fig. 19 Anatomic Pathology Market: Product & Service movement analysis & market share 2024 & 2030
  • Fig. 20 Products Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Instruments Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Microtomes & Cryostat Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Automatic Stainers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Whole Slide Imaging (WSI) Scanners Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Other Products Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Consumables Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Reagents & Antibodies Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Probes & Kits Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Others Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Services Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Anatomic Pathology Market: Product & Service outlook and key takeaways
  • Fig. 32 Anatomic Pathology Market: Product & Service movement analysis & market share 2024 & 2030
  • Fig. 33 Hospitals Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Diagnostic Laboratories Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Research Laboratories Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Others Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Global Anatomic Pathology Market: Regional movement analysis
  • Fig. 39 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Canada Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Europe Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 UK Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Germany Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 France Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Italy Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Spain Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Norway Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Asia-Pacific Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Japan Market Estimates and Forecast, 2021 - 2033(USD Million)
  • Fig. 53 China Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 54 India Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 55 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Australia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 MEA Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 62 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 64 UAE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Strategy framework